Annual report pursuant to Section 13 and 15(d)

NOTE 6 - STOCK OPTIONS

v3.7.0.1
NOTE 6 - STOCK OPTIONS
12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
NOTE 6 - STOCK OPTIONS

NOTE 6 - STOCK OPTIONS

During the year ended December 31, 2016 no stock options were issued. The Director options were supposed to be issued as their fee for being board members but were not issued. The options will be issued in 2017.

During the year ended December 31, 2016 the Company issued 1,130,000 warrants and recorded an equity compensation expense of $163,574 equal to the estimated fair value of the options at the date of grants. The fair market value was calculated using the Black-Scholes options pricing model, assuming approximately 0.41% risk-free interest, 0% dividend yield, 265% volatility, and expected life of 3 years.

No stock options or warrants were exercised during the year ended December 31, 2016.

During the year ended December 31, 2015, the Company issued 300,000 options to the Company’s directors. The directors each received 100,000 options for serving as board members in 2015. An additional 300,000 options were issued to the Chief Financial Officer of the Company. The stock options allow each director to purchase 100,000 shares of the Company’s common stock at $0.13 per share per each individual option. The stock options to the Company’s Chief Financial Officer allow for the purchase of 300,000 shares of the Company’s common stock at $0.13 per share per each individual option. The options expire on June 29, 2020.

During the year ended December 31, 2015, the Company recorded an Equity compensation expense of $45,946 equal to the estimated fair value of the options at the date of grants. The fair market value was calculated using the Black-Scholes options pricing model, assuming approximately 1.63% risk-free interest, 0% dividend yield, 175% volatility, and expected life of 5 years.

During the year ended December 31, 2015, the Company issued 55,000 warrants and recorded a warrant expense of $7,036 equal to the estimated fair value of the options at the date of grants. The fair market value was calculated using the Black-Scholes options pricing model, assuming approximately 1.63% risk-free interest, 0% dividend yield, 271% volatility, and expected life of 3 years.

No stock options or warrants were exercised during the year ended December 31, 2015.

Stock options outstanding and exercisable as of December 31, 2016 are as follows:
         
Exercise Price per Share   Shares Under Option   Remaining Life in Years
  Outstanding                  
$ 0.08       450,000       2.00  
$ 0.025       200,000       1.00  
$ 0.025       500,000       0.97  
$ 0.01       4,500,000       0.67  
$ 0.13       600,000       3.50  
$ 0.15       1,000,000       2.39  
$ 0.25       1,000,000       2.39  
$ 0.35       1,000,000       2.39  
          9,250,000          
  Exercisable                  
$ 0.08       450,000       2.00  
$ 0.025       200,000       1.00  
$ 0.025       500,000       0.97  
$ 0.01       4,500,000       0.67  
$ 0.13       600,000       3.50  
$ 0.15       1,000,000       2.39  
$ 0.25        1,000,000       2.39  
          8,250,000